Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05793177
Other study ID # MONSS
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date December 31, 2024

Study information

Verified date March 2023
Source Zealand University Hospital
Contact Stefan S Bodilsen, MSPT
Phone +4528401595
Email sbodi@regionsjaelland.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized control trial (RCT) aims to test the effect of a 12 weeks tailored behavioral intervention on stroke survivors living in the community and compare the results to a control group of stroke survivors participating in standard care. The intervention's purpose is to lower the time spend with sedentary behavior and raise the level of physical activity in stroke survivors throughout their everyday life. The intervention contains two motivational interviews with a focus on goal setting, action planning, motivation, fatigue management, and general information on life after stroke. The primary outcome for behavior change is objectively measured physical activity using an activity tracker (ActivPal4 Micro) and secondary glycohemoglobin and changes in quality of life.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 31, 2024
Est. primary completion date October 1, 2024
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Verified ischemic stroke or intracerebral hemorrhage - Modified rankin score (mRS) 1-3 at discharge - Discharged with at rehabilitation plan within 1-14 hospitalization days - Able to ambulate independently - Speak and understand Danish Exclusion Criteria: - Aphasia - Unable to give informed consent - Unable to ambulate independently - Mental illness - Other co-morbidity like terminal cancer.

Study Design


Intervention

Behavioral:
Everyday Life is Rehabilitation
Behavior change intervention focuses on implementing more movement into everyday life using action planning, goal setting, and fatigue management.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Zealand University Hospital

References & Publications (1)

Bodilsen SS, Aadahl M, Wienecke T, Thomsen TH. Development of a tailored intervention targeting sedentary behavior and physical activity in people with stroke and diabetes: A qualitative study using a co-creation framework. Front Rehabil Sci. 2023 Feb 13;4:1114537. doi: 10.3389/fresc.2023.1114537. eCollection 2023. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sedentary time Time participants spend with sedentary behavior compared between the intervention and control group 12 weeks follow-up
Secondary Physical activity scale (PAS2) Subjective physical activity Baseline,12 and 26 weeks follow-up
Secondary The Stroke Specific Quality of Life Scale (SS-QOL) Quality of life Baseline,12 and 26 weeks follow-up
Secondary The General Self-efficacy Scale (GSES) self-efficacy Baseline,12 and 26 weeks follow-up
Secondary The Multi-dimensional Fatigue Inventory (MFI-20) questionnaire Fatigue Baseline,12 and 26 weeks follow-up
Secondary Patient health questionnaire (PHQ-9) Depression symptoms Baseline,12 and 26 weeks follow-up
Secondary The Fugl Meyer Assessment (FMA) The function of upper and lower extremity Baseline,12 and 26 weeks follow-up
Secondary Timed Up & Go (TUG) test Mobility Baseline,12 and 26 weeks follow-up
Secondary Montreal Cognitive Assessment (MoCA) cognitive assessment Baseline
Secondary Glycated hemoglobin (HbA1c) Glycated hemoglobin (HbA1c) Baseline,6,12 and 26 weeks follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT05378035 - DOAC in Chinese Patients With Atrial Fibrillation
Completed NCT03574038 - Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke N/A
Completed NCT03679637 - Tablet-based Aphasia Therapy in the Acute Phase After Stroke N/A
Completed NCT03633422 - Evaluation of Stroke Patient Screening
Completed NCT04088578 - VNS-supplemented Motor Retraining After Stroke N/A
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Not yet recruiting NCT05534360 - Tenecteplase Treatment in Ischemic Stroke Registry
Not yet recruiting NCT04105322 - Effects of Kinesio Taping on Balance and Functional Performance in Stroke Patients N/A
Withdrawn NCT05786170 - ERILs Und SNILs Unter SOC N/A
Recruiting NCT03132558 - Contrast Induced Acute Kidney in Patients With Acute Stroke N/A
Completed NCT02893631 - Assessment of Hemostasis Disorders in rtPA-treated Patients Requiring Endovascular Treatment for Ischemic Stroke
Active, not recruiting NCT02274727 - Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study
Completed NCT02225730 - Imaging Collaterals in Acute Stroke (iCAS)
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Active, not recruiting NCT01581502 - SAMURAI-NVAF Study: Anticoagulant Therapy for Japanese Stroke Patients With Nonvalvular Atrial Fibrillation (NVAF) N/A
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT00761982 - Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment. Phase 1/Phase 2
Completed NCT00535197 - Autologous Bone Marrow Stem Cells in Ischemic Stroke. Phase 1/Phase 2
Terminated NCT00132509 - FRALYSE Trial: Comparison of the Classical Rt-PA Procedure With a Longer Procedure in Acute Ischemic Stroke Phase 2
Recruiting NCT05760326 - Diagnostic and Prognostic Role of Clot Analysis in Stroke Patients